Literature DB >> 26860865

Facioscapulohumeral dystrophy myoblasts efficiently repair moderate levels of oxidative DNA damage.

Yara Bou Saada1, Carla Dib1, Petr Dmitriev1, Aline Hamade2, Gilles Carnac3, Dalila Laoudj-Chenivesse3, Marc Lipinski1, Yegor S Vassetzky4,5.   

Abstract

Facioscapulohumeral dystrophy (FSHD) is a progressive muscular dystrophy linked to a deletion of a subset of D4Z4 macrosatellite repeats accompanied by a chromatin relaxation of the D4Z4 array on chromosome 4q. In vitro, FSHD primary myoblasts show altered expression of oxidative-related genes and are more susceptible to oxidative stress. Double homeobox 4 (DUX4) gene, encoded within each D4Z4 unit, is normally transcriptionally silenced but is found aberrantly expressed in skeletal muscles of FSHD patients. Its expression leads to a deregulation of DUX4 target genes including those implicated in redox balance. Here, we assessed DNA repair efficiency of oxidative DNA damage in FSHD myoblasts and DUX4-transfected myoblasts. We have shown that the DNA repair activity is altered neither in FSHD myoblasts nor in immortalized human myoblasts transiently expressing DUX4. DNA damage caused by moderate doses of an oxidant is efficiently repaired while FSHD myoblasts exposed for 24 h to high levels of oxidative stress accumulated more DNA damage than normal myoblasts, suggesting that FSHD myoblasts remain more vulnerable to oxidative stress at high doses of oxidants.

Entities:  

Keywords:  DNA damage; DNA repair; DUX4; Facioscapulohumeral dystrophy; Oxidative stress

Mesh:

Substances:

Year:  2016        PMID: 26860865     DOI: 10.1007/s00418-016-1410-2

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  64 in total

1.  Cancer risk among patients with myotonic muscular dystrophy.

Authors:  Shahinaz M Gadalla; Marie Lund; Ruth M Pfeiffer; Sanne Gørtz; Christine M Mueller; Richard T Moxley; Sigurdur Y Kristinsson; Magnus Björkholm; Fatma M Shebl; James E Hilbert; Ola Landgren; Jan Wohlfahrt; Mads Melbye; Mark H Greene
Journal:  JAMA       Date:  2011-12-14       Impact factor: 56.272

2.  High prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomas.

Authors:  Antoine Italiano; Yun Shao Sung; Lei Zhang; Samuel Singer; Robert G Maki; Jean-Michel Coindre; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2011-11-10       Impact factor: 5.006

3.  Oxidative stress and tumour cell proliferation.

Authors:  R H Burdon; V Gill; C Rice-Evans
Journal:  Free Radic Res Commun       Date:  1990

4.  Unusual association of FSHD and extramedullary thoracic tumour in the same patient: a case report.

Authors:  V Kazakov; D Rudenko; J Schulev; A Pozdnyakov
Journal:  Acta Myol       Date:  2009-10

Review 5.  Rare hereditary diseases with defects in DNA-repair.

Authors:  Jennifer Knoch; York Kamenisch; Christian Kubisch; Mark Berneburg
Journal:  Eur J Dermatol       Date:  2012 Jul-Aug       Impact factor: 3.328

6.  DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy.

Authors:  Linda N Geng; Zizhen Yao; Lauren Snider; Abraham P Fong; Jennifer N Cech; Janet M Young; Silvere M van der Maarel; Walter L Ruzzo; Robert C Gentleman; Rabi Tawil; Stephen J Tapscott
Journal:  Dev Cell       Date:  2011-12-29       Impact factor: 12.270

7.  The FSHD-associated repeat, D4Z4, is a member of a dispersed family of homeobox-containing repeats, subsets of which are clustered on the short arms of the acrocentric chromosomes.

Authors:  R Lyle; T J Wright; L N Clark; J E Hewitt
Journal:  Genomics       Date:  1995-08-10       Impact factor: 5.736

8.  On the significance of retinal vascular disease and hearing loss in facioscapulohumeral muscular dystrophy.

Authors:  G W Padberg; O F Brouwer; R J de Keizer; G Dijkman; C Wijmenga; J J Grote; R R Frants
Journal:  Muscle Nerve Suppl       Date:  1995

9.  Mice lacking dystrophin or alpha sarcoglycan spontaneously develop embryonal rhabdomyosarcoma with cancer-associated p53 mutations and alternatively spliced or mutant Mdm2 transcripts.

Authors:  Karen Fernandez; Yelda Serinagaoglu; Sue Hammond; Laura T Martin; Paul T Martin
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

10.  Cancer-related genes in the transcription signature of facioscapulohumeral dystrophy myoblasts and myotubes.

Authors:  Petr Dmitriev; Ulykbek Kairov; Thomas Robert; Ana Barat; Vladimir Lazar; Gilles Carnac; Dalila Laoudj-Chenivesse; Yegor S Vassetzky
Journal:  J Cell Mol Med       Date:  2013-12-17       Impact factor: 5.310

View more
  8 in total

1.  HIV Tat induces a prolonged MYC relocalization next to IGH in circulating B-cells.

Authors:  D Germini; T Tsfasman; M Klibi; R El-Amine; A Pichugin; O V Iarovaia; C Bilhou-Nabera; F Subra; Y Bou Saada; A Sukhanova; D Boutboul; M Raphaël; J Wiels; S V Razin; S Bury-Moné; E Oksenhendler; M Lipinski; Y S Vassetzky
Journal:  Leukemia       Date:  2017-03-31       Impact factor: 11.528

Review 2.  Control of DNA integrity in skeletal muscle under physiological and pathological conditions.

Authors:  Yara Bou Saada; Vlada Zakharova; Boris Chernyak; Carla Dib; Gilles Carnac; Svetlana Dokudovskaya; Yegor S Vassetzky
Journal:  Cell Mol Life Sci       Date:  2017-04-25       Impact factor: 9.261

3.  Identification of the hyaluronic acid pathway as a therapeutic target for facioscapulohumeral muscular dystrophy.

Authors:  Alec M DeSimone; John Leszyk; Kathryn Wagner; Charles P Emerson
Journal:  Sci Adv       Date:  2019-12-11       Impact factor: 14.136

Review 4.  Cellular and animal models for facioscapulohumeral muscular dystrophy.

Authors:  Alec M DeSimone; Justin Cohen; Monkol Lek; Angela Lek
Journal:  Dis Model Mech       Date:  2020-10-28       Impact factor: 5.758

5.  Analysis of genes regulated by DUX4 via oxidative stress reveals potential therapeutic targets for treatment of facioscapulohumeral dystrophy.

Authors:  Anna Karpukhina; Ivan Galkin; Yinxing Ma; Carla Dib; Roman Zinovkin; Olga Pletjushkina; Boris Chernyak; Ekaterina Popova; Yegor Vassetzky
Journal:  Redox Biol       Date:  2021-05-13       Impact factor: 11.799

6.  RIPK3-mediated cell death is involved in DUX4-mediated toxicity in facioscapulohumeral dystrophy.

Authors:  Virginie Mariot; Romain Joubert; Laura Le Gall; Eva Sidlauskaite; Christophe Hourde; William Duddy; Thomas Voit; Maximilien Bencze; Julie Dumonceaux
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-10-22       Impact factor: 12.910

7.  A patient-derived iPSC model revealed oxidative stress increases facioscapulohumeral muscular dystrophy-causative DUX4.

Authors:  Mitsuru Sasaki-Honda; Tatsuya Jonouchi; Meni Arai; Akitsu Hotta; Satomi Mitsuhashi; Ichizo Nishino; Ryoichi Matsuda; Hidetoshi Sakurai
Journal:  Hum Mol Genet       Date:  2018-12-01       Impact factor: 6.150

Review 8.  DUX4 Signalling in the Pathogenesis of Facioscapulohumeral Muscular Dystrophy.

Authors:  Kenji Rowel Q Lim; Quynh Nguyen; Toshifumi Yokota
Journal:  Int J Mol Sci       Date:  2020-01-22       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.